Comirnaty Gives Booster Shot To Pfizer Q3 Sales
Vaccine Drives Revenues Up 130%
The company increased its guidance for sales of the COVID-19 vaccine again, to $36bn, though many other products’ sales were close to or below analyst expectations.
The company increased its guidance for sales of the COVID-19 vaccine again, to $36bn, though many other products’ sales were close to or below analyst expectations.